255 related articles for article (PubMed ID: 12409715)
21. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
22. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
[TBL] [Abstract][Full Text] [Related]
23. Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
Ebisch RMF; Rijstenberg LL; Soltani GG; van der Horst J; Vedder JEM; Hermsen M; Bosgraaf RP; Massuger LFAG; Meijer CJLM; Heideman DAM; van Kemenade FJ; Melchers WJG; Bekkers RLM; Siebers AG; Bulten J
Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1328-1336. PubMed ID: 36177908
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Baruch AC; Silva EG; Jan YJ; Lin E; Sneige N; Deavers MT
Am J Clin Pathol; 2011 Feb; 135(2):212-20. PubMed ID: 21228361
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
[TBL] [Abstract][Full Text] [Related]
26. p16INK4a immunohistochemical and histopathologic study of Pap test cases interpreted as HSIL without CIN2-3 identification in subsequent cervical specimens.
Solano FJ; Rush DS; Wilkinson EJ
Int J Gynecol Pathol; 2015 May; 34(3):215-20. PubMed ID: 25844545
[TBL] [Abstract][Full Text] [Related]
27. Decreased D2-40 and increased p16INK4A immunoreactivities correlate with higher grade of cervical intraepithelial neoplasia.
Han H; Yang Y; Lu Z; He Q; Lin Z
Diagn Pathol; 2011 Jul; 6():59. PubMed ID: 21729305
[TBL] [Abstract][Full Text] [Related]
28. Diagnosing cervical biopsies in adolescents: the use of p16 immunohistochemistry to improve reliability and reproducibility.
Sayed K; Korourian S; Ellison DA; Kozlowski K; Talley L; Horn HV; Simpson P; Parham DM
J Low Genit Tract Dis; 2007 Jul; 11(3):141-6. PubMed ID: 17596758
[TBL] [Abstract][Full Text] [Related]
29. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
30. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
31. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
32. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
Kuo KT; Chang HC; Hsiao CH; Lin MC
Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
[TBL] [Abstract][Full Text] [Related]
33. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
Murphy N; Ring M; Heffron CC; King B; Killalea AG; Hughes C; Martin CM; McGuinness E; Sheils O; O'Leary JJ
J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
[TBL] [Abstract][Full Text] [Related]
34. Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations.
Nassar A; O'Reilly K; Cohen C; Siddiqui MT
Diagn Cytopathol; 2008 Mar; 36(3):142-8. PubMed ID: 18232003
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
Celewicz A; Celewicz M; Wężowska M; Chudecka-Głaz A; Menkiszak J; Urasińska E
Pol J Pathol; 2018; 69(1):42-47. PubMed ID: 29895125
[TBL] [Abstract][Full Text] [Related]
36. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
Wang R; Li X; Qian M; Niu J; You Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
[TBL] [Abstract][Full Text] [Related]
37. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
38. Value of p16(INK4a) as a marker of progression/regression in cervical intraepithelial neoplasia grade 1.
del Pino M; Garcia S; Fusté V; Alonso I; Fusté P; Torné A; Ordi J
Am J Obstet Gynecol; 2009 Nov; 201(5):488.e1-7. PubMed ID: 19683687
[TBL] [Abstract][Full Text] [Related]
39. P16INK4A as an adjunct test in liquid-based cytology.
Bibbo M; DeCecco J; Kovatich AJ
Anal Quant Cytol Histol; 2003 Feb; 25(1):8-11. PubMed ID: 12630076
[TBL] [Abstract][Full Text] [Related]
40. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
